pgCAR激动剂高通量药物筛选模型的建立
首发时间:2012-09-24
摘要:主要目的是构建猪组成型雄甾烷受体(pgCAR)激动剂的体外高通量筛选模型。利用RT-PCR技术从猪肝脏的总RNA中扩增出pgCAR基因序列,将此序列连接到pMD-18T vector 上进行测序。将正确的pgCAR片段连接到pcDNA 3.1 vector上构建表达载体pcDNA 3.1-CAR;将合成的5个拷贝的NR1(nuclear receptor sites)插入PGL3-TK-promoter构成报告质粒(NR1)5-TK-luc,与PRL -TK 报告质粒构成双荧光报告系统。用PEI 转染技术将表达载体与报告质粒共转染HepG 2细胞株中,通过检测荧光素酶基因的表达状况评价化合物对pgCAR的激动活性。阳性药苯妥英钠明显提高荧光素酶的表达,最大上调倍增数可达约2.53倍,并且在一定浓度下阳性药与相对荧光酶的活性表达有较好的量效关系。
For information in English, please click here
Establishment of a cell-base high-throughout screening model for pig CAR agonist
Abstract:To establish a new high-throughput screening model for the agonist of pgCAR (pig constitutive androstane receptor), pgCAR gene was obtained by reverse transcriptase-polymerase chain reaction (RT-PCR), and cloned to pMD-18T Vector for sequencing, then the pgCAR fragment was excised by restriction enzymes, and inserted into pcDNA3.1 Vector to construct expression vector pcDNA3.1-CAR. Insert five copies of NR1 into pGl3-TK promoter vector to construct expression vector (NR1)5-TK-luc. The vector pcDNA3.1-CAR was transiently cotransfected by liposome technology with (NR1)5-TK-luc and pRL-TK Vector into HepG2 cell lines to assay the expression levels of luciferase and evaluate the exciting activity of agonist phenytoin. Finally, phenytoin a positive drug significantly improved the expression level of luciferase, the maximum multiple is up to about 2.53 fold, and it had good dose-effect relationship between positive drug and the relative luciferase expression in a certain concentration of positive drug.
Keywords: pgCAR agonist cotransfection high-throughput screening
基金:
论文图表:
引用
No.****
同行评议
共计0人参与
勘误表
pgCAR激动剂高通量药物筛选模型的建立
评论
全部评论0/1000